SEDECAL SA recalled 12 units of its Mobile X-ray system on June 10, 2025, due to water resistance issues. Users must adhere to strict cleaning instructions to avoid equipment damage. The recall affects units distributed in California, Illinois, and New Jersey.
Sedecal sent an email to its consignees to remind the users that the equipment is not water-resistant and must be cleaned strictly according to the instructions in the manual, clearly outlining the possible consequences of improper cleaning.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact SEDECAL SA or your healthcare provider for instructions. Notification method: E-Mail
The recalled product is the Model Number 40KWFXPLUS.005 Mobile X-ray system. It has model numbers including UDI/DI 08436046002166 and serial numbers such as G82576, G82871, and G78884. The units were distributed in California, Illinois, and New Jersey.
The Mobile X-ray system is not water-resistant, posing a risk of malfunction if cleaned improperly. Failure to follow the cleaning instructions can lead to equipment failure.
There are no reported injuries or incidents associated with this recall. However, the importance of proper cleaning and maintenance is emphasized.
Stop using the Mobile X-ray system immediately. Follow the recall instructions provided by Sedecal. Contact SEDECAL SA or your healthcare provider for further instructions.
For more information, visit the SEDECAL website or contact your healthcare provider. Additional details can be found at the FDA recall page.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.